ARDT

Ardent Health, Inc. 10-Q Summary: Q2 2026

Business Context and Reporting Period

This report covers the quarterly period ended June 30, 2026. Ardent Health, Inc. operates a network of 30 acute care hospitals, two rehabilitation hospitals, and two surgical hospitals across six states (Texas, Oklahoma, New Mexico, New Jersey, Idaho, and Kansas). The company utilizes a joint venture model, often partnering with academic medical centers and not-for-profit systems, and leases a significant portion of its real estate from Ventas, Inc. under a master lease agreement.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Decline (Q2): Total revenue decreased 1.4% year-over-year in Q2 2026. This was driven by a 3.9% decrease in net patient service revenue per adjusted admission, primarily due to a $57.8 million reduction in Medicaid supplemental payment revenue. This reduction resulted from the delayed renewal of New Mexico's Medicaid program in the prior year, which had recognized two quarters of revenue in Q2 2025.
• Revenue Growth (YTD): For the six months ended June 30, 2026, revenue increased 2.6% year-over-year, driven by a 2.3% increase in adjusted admissions and a 0.6% increase in revenue per adjusted admission.
• Profitability Compression: Net income attributable to Ardent Health dropped significantly (76.5% in Q2 and 50.4% YTD) compared to the prior year. This decline is largely attributable to the one-time revenue boost in the prior year from New Mexico and increased operating expenses.
• Expense Increases: Professional fees increased as a percentage of revenue (20.2% in Q2 2026 vs. 18.1% in Q2 2025) due to rising physician-related expenses. Other operating expenses also rose due to higher provider assessments and professional liability costs.
• Restructuring Costs: The company incurred significant non-recurring costs related to enterprise restructuring and CEO transition, including severance, totaling $27.2 million in Q2 2026 and $35.0 million YTD 2026.

Guidance, Outlook, and Risks

• Regulatory Impact (OBBBA): The "One Big Beautiful Bill Act" (OBBBA) passed in July 2025 introduces changes to Medicaid eligibility, funding mechanisms, and tax laws. Management expects these changes, particularly the reduction in Medicaid supplemental payments and the expiration of ACA subsidies, to adversely impact financial performance in 2026.
• Liquidity: As of June 30, 2026, the company reported total available liquidity of $992.5 million, comprising $724.5 million in cash and $268.0 million in available capacity under its Asset-Based Lending (ABL) facility. The net leverage ratio was 0.8x.
• Legal Proceedings:
  • Securities Litigation: A putative class action lawsuit (Postiwala v. Ardent Health, Inc.) alleges false reporting of accounts receivable and insurance reserves. The company intends to vigorously defend the claims.
  • SEC Inquiry: The SEC has initiated a non-public, fact-finding inquiry regarding a $43 million revenue decrease related to accounts receivable collectability reported in late 2025.
  • Cybersecurity: Litigation related to a 2023 ransomware incident was settled in 2024; no material insurance recoveries were received in the first half of 2026.
• Capital Allocation: The company repurchased $13.0 million of common stock in the first half of 2026 under a $50 million authorization program. Approximately $33.7 million of authorization remains.

Investor Verification Checklist

• Medicaid Revenue Sustainability: Verify the long-term impact of the New Mexico Medicaid supplemental payment program renewal delay and the potential revenue headwinds from the OBBBA legislation.
• SEC Inquiry Status: Monitor developments regarding the SEC's fact-finding inquiry into the $43 million revenue adjustment and the related securities class action lawsuit.
• Restructuring Execution: Assess whether the reported restructuring costs ($35M YTD) will yield the anticipated efficiency gains and if further workforce reductions are planned.
• Physician Cost Inflation: Evaluate the trend in professional fees, which rose significantly as a percentage of revenue, and the company's ability to pass these costs to payors.
• Debt Covenants: Confirm continued compliance with the Ventas Master Lease covenants (minimum portfolio coverage ratio of 2.2x) and Senior Secured Credit Facility terms given the current leverage ratios.